Dr. Travis Van Meter, MD
What this data tells you about Dr. Van Meter
Dr. Travis Van Meter is a radiation oncology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Van Meter performed 18,174 Medicare services across 1,197 unique beneficiaries.
Between the years covered by Open Payments, Dr. Van Meter received a total of $39,994 from 36 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Van Meter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, propofol, 10 mg | 7,425 | $0 | $0 |
| Contrast dye for imaging, lower concentration | 3,398 | $0 | $19 |
| Contrast dye for imaging (iodine-based) | 3,392 | $0 | $19 |
| Anti-nausea injection (ondansetron/Zofran) | 938 | $0 | $0 |
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 711 | $0 | $0 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 560 | $0 | $0 |
| Dexamethasone injection (steroid) | 145 | $0 | $1 |
| Unclassified drugs | 139 | $2 | $150 |
| Review by radiologist of additional artery image | 138 | $76 | $339 |
| Ultrasonic guidance for blood vessel access | 116 | $31 | $175 |
| Injection, cefazolin sodium, 500 mg | 110 | $1 | $3 |
| Injection, heparin sodium, per 1000 units | 102 | $0 | $1 |
| Review by radiologist of abdominal artery image | 90 | $133 | $593 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 80 | $622 | $7,195 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 73 | $132 | $807 |
| Injection, midazolam hydrochloride, per 1 mg | 67 | $0 | $0 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 63 | $91 | $597 |
| Occlusion of growths or obstructed vessels with review by radiologist | 54 | $6,734 | $39,259 |
| Injection, nitroglycerin, 5 mg | 54 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 41 | $160 | $840 |
| Complex radiation therapy planning | 35 | $130 | $690 |
| Calculation of radiation therapy dose | 35 | $51 | $275 |
| Radioelements for brachytherapy, any type, each | 35 | $13,677 | $20,361 |
| Special radiation treatment | 34 | $108 | $544 |
| Nuclear medicine study of liver | 31 | $140 | $800 |
| Radioactive drug therapy through a tube inserted in an artery | 30 | $100 | $471 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 28 | $134 | $708 |
| Fluoroscopic guidance for needle placement | 28 | $81 | $256 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 27 | $487 | $5,443 |
| Injection, ketorolac tromethamine, per 15 mg | 26 | $0 | $2 |
| Occlusion of artery with review by radiologist | 24 | $5,620 | $30,866 |
| Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 23 | $119 | $730 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 22 | $750 | $5,216 |
| Nuclear medicine study, multiple areas | 22 | $199 | $1,200 |
| Blood glucose (sugar) test performed by hand-held instrument | 15 | $3 | $13 |
| Office visit, established patient, complex (40-54 min) | 15 | $136 | $594 |
| Blood creatinine level | 13 | $5 | $25 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 12 | $79 | $371 |
| Injection, hydromorphone, up to 4 mg | 12 | $3 | $13 |
| New patient office visit (30-44 min) | 11 | $60 | $357 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in radiation oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for radiation oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Van Meter is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Van Meter experienced with injection, propofol, 10 mg?
Does Dr. Van Meter receive payments from pharmaceutical companies?
How do Dr. Van Meter's costs compare to other radiation oncologys in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology